Exosome mimetics: a novel class of drug delivery systems

The identification of extracellular phospholipid vesicles as conveyors of cellular information has created excitement in the field of drug delivery. Biological therapeutics, including short interfering RNA and recombinant proteins, are prone to degradation, have limited ability to cross biological membranes, and may elicit immune responses. Therefore, delivery systems for such drugs are under intensive investigation. Exploiting extracellular vesicles as carriers for biological therapeutics is a promising strategy to overcome these issues and to achieve efficient delivery to the cytosol of target cells. Exosomes are a well studied class of extracellular vesicles known to carry proteins and nucleic acids, making them especially suitable for such strategies. However, the considerable complexity and the related high chance of off-target effects of these carriers are major barriers for translation to the clinic. Given that it is well possible that not all components of exosomes are required for their proper functioning, an alternative strategy would be to mimic these vesicles synthetically. By assembly of liposomes harboring only crucial components of natural exosomes, functional exosome mimetics may be created. The low complexity and use of well characterized components strongly increase the pharmaceutical acceptability of such systems. However, exosomal components that would be required for the assembly of functional exosome mimetics remain to be identified. This review provides insights into the composition and functional properties of exosomes, and focuses on components which could be used to enhance the drug delivery properties of exosome mimetics.

[1]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  D. Otzen,et al.  Lactadherin binds to phosphatidylserine-containing vesicles in a two-step mechanism sensitive to vesicle size and composition. , 2012, Biochimica et biophysica acta.

[3]  Yang-Hsin Shih,et al.  Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. , 2012, Biomaterials.

[4]  Simon C Watkins,et al.  Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. , 2012, Blood.

[5]  Ping Wang,et al.  Expression and characterization of recombinant human milk fat globule-EGF factor VIII. , 2011, International journal of molecular medicine.

[6]  J. Le Pecq,et al.  Increasing vaccine potency through exosome antigen targeting. , 2011, Vaccine.

[7]  R. Gambari,et al.  Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. , 2011, Biochemical pharmacology.

[8]  S. Fuller,et al.  The human P2X7 receptor and its role in innate immunity. , 2011, Tissue antigens.

[9]  Eun Hye Lim,et al.  Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. , 2011, Gynecologic oncology.

[10]  Tyler E. Miller,et al.  Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal* , 2011, The Journal of Biological Chemistry.

[11]  I. Conboy,et al.  Phosphatidylserine directly and positively regulates fusion of myoblasts into myotubes. , 2011, Biochemical and biophysical research communications.

[12]  Suresh Mathivanan,et al.  ExoCarta 2012: database of exosomal proteins, RNA and lipids , 2011, Nucleic Acids Res..

[13]  Patricia Bassereau,et al.  Functional Reconstitution of a Voltage-Gated Potassium Channel in Giant Unilamellar Vesicles , 2011, PloS one.

[14]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[15]  M. Wood,et al.  Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  Bernd Giebel,et al.  Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. , 2011, Colloids and surfaces. B, Biointerfaces.

[18]  H. Perlman,et al.  Exosomes From Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine Activity , 2011, Circulation research.

[19]  Thomas D. Schmittgen,et al.  microRNA Replacement Therapy for Cancer , 2011, Pharmaceutical Research.

[20]  T. V. Kolesnikova,et al.  The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization , 2011, Journal of Cell Science.

[21]  Hamid Cheshmi Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[22]  S. Mandl,et al.  Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. , 2011, Cancer research.

[23]  Won Jong Kim,et al.  Polymers in small-interfering RNA delivery. , 2011, Nucleic acid therapeutics.

[24]  R. Andriantsitohaina,et al.  Microparticles in angiogenesis: therapeutic potential. , 2011, Circulation research.

[25]  Ç. Gerçel-Taylor,et al.  Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments , 2011, Seminars in Immunopathology.

[26]  B. Burwinkel,et al.  Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.

[27]  M. Record,et al.  Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.

[28]  Eric O Long ICAM-1: Getting a Grip on Leukocyte Adhesion , 2011, The Journal of Immunology.

[29]  M. Kesimer,et al.  Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. , 2011, Experimental cell research.

[30]  S. Lim,et al.  Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs , 2011, Journal of Translational Medicine.

[31]  Takashi Takata,et al.  miR-22 represses cancer progression by inducing cellular senescence , 2011, The Journal of cell biology.

[32]  H. Nakanishi,et al.  Phosphatidylserine-Containing Liposomes: Potential Pharmacological Interventions Against Inflammatory and Immune Diseases Through the Production of Prostaglandin E2 After Uptake by Myeloid Derived Phagocytes , 2011, Archivum Immunologiae et Therapiae Experimentalis.

[33]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[34]  Gunther Hartmann,et al.  SiRNA delivery with exosome nanoparticles , 2011, Nature Biotechnology.

[35]  S. Crawford,et al.  Effect of Increased Extracellular Ca++ on Microvesicle Production and Tumor Spheroid Formation , 2011, Cancer Microenvironment.

[36]  Shoshannah L. Roth,et al.  Promotion of vesicular stomatitis virus fusion by the endosome‐specific phospholipid bis(monoacylglycero)phosphate (BMP) , 2011, FEBS letters.

[37]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[38]  I. Campbell,et al.  Integrin structure, activation, and interactions. , 2011, Cold Spring Harbor perspectives in biology.

[39]  Beiyi Shen,et al.  Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors* , 2011, The Journal of Biological Chemistry.

[40]  F. Magni,et al.  Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery , 2011, Proteomics.

[41]  K. Kelnar,et al.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.

[42]  I. Mérida,et al.  Diacylglycerol kinase α regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes , 2011, Cell Death and Differentiation.

[43]  J. Freyssinet,et al.  Cellular Mechanisms Underlying the Formation of Circulating Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[44]  E. Stępień,et al.  Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro , 2010, Cellular & Molecular Biology Letters.

[45]  N. Raab-Traub,et al.  Human tumor virus utilizes exosomes for intercellular communication , 2010, Proceedings of the National Academy of Sciences.

[46]  Willem Stoorvogel,et al.  MHC class II‐associated proteins in B‐cell exosomes and potential functional implications for exosome biogenesis , 2010, Immunology and cell biology.

[47]  G. Lip,et al.  Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis , 2010, Journal of thrombosis and haemostasis : JTH.

[48]  Haitao Wang,et al.  Visualizing of the cellular uptake and intracellular trafficking of exosomes by live‐cell microscopy , 2010, Journal of cellular biochemistry.

[49]  L. Chernomordik,et al.  Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids , 2010, PLoS pathogens.

[50]  R. Salter,et al.  Activation of Macrophages by P2X7-Induced Microvesicles from Myeloid Cells Is Mediated by Phospholipids and Is Partially Dependent on TLR4 , 2010, The Journal of Immunology.

[51]  S. Kota,et al.  Cancer therapy via modulation of micro RNA levels: a promising future. , 2010, Drug discovery today.

[52]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[53]  Bernard Monsarrat,et al.  Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins[S] , 2010, Journal of Lipid Research.

[54]  J. Inal,et al.  Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE. , 2010, Biochemical and biophysical research communications.

[55]  Y. S. Tarahovsky “Smart” liposomal nanocontainers in biology and medicine , 2010, Biochemistry (Moscow).

[56]  D. Guidolin,et al.  C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. , 2010, Experimental cell research.

[57]  G. Tuszynski,et al.  Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin α6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion , 2010, Journal of oncology.

[58]  F. Reig,et al.  Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin , 2010, Journal of peptide science : an official publication of the European Peptide Society.

[59]  T. Giordano,et al.  B-RafV600E and thrombospondin-1 promote thyroid cancer progression , 2010, Proceedings of the National Academy of Sciences.

[60]  Crislyn D'Souza-Schorey,et al.  Microvesicles: mediators of extracellular communication during cancer progression , 2010, Journal of Cell Science.

[61]  C. Reutelingsperger,et al.  Phosphatidylserine targeting for diagnosis and treatment of human diseases , 2010, Apoptosis.

[62]  U. Švajger,et al.  C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity , 2010, Cellular Signalling.

[63]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[64]  C. Gregory,et al.  Microenvironmental influences of apoptosis in vivo and in vitro , 2010, Apoptosis.

[65]  Peixuan Guo,et al.  Engineering RNA for Targeted siRNA Delivery and Medical Application , 2010, Advanced Drug Delivery Reviews.

[66]  Aled Clayton,et al.  Proteomics Analysis of Bladder Cancer Exosomes* , 2010, Molecular & Cellular Proteomics.

[67]  K. Preissner,et al.  Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. , 2010, Cancer research.

[68]  N. Picollet-D'hahan,et al.  A Simple Method for the Reconstitution of Membrane Proteins into Giant Unilamellar Vesicles , 2010, Journal of Membrane Biology.

[69]  S. Mathivanan,et al.  ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.

[70]  Marilena Loizidou,et al.  Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.

[71]  Richard J. Simpson,et al.  Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature* , 2009, Molecular & Cellular Proteomics.

[72]  T. Rana,et al.  Delivery of Therapeutic RNAi by Nanovehicles , 2009, Chembiochem : a European journal of chemical biology.

[73]  J. Xiang,et al.  Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses. , 2009, Cancer research.

[74]  P. Bassereau,et al.  Integrin reconstituted in GUVs: a biomimetic system to study initial steps of cell spreading. , 2009, Biochimica et biophysica acta.

[75]  A. Molinari,et al.  Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.

[76]  M. Wewers,et al.  Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1 , 2009, PloS one.

[77]  J. Swartz,et al.  Cell‐free synthesis of functional aquaporin Z in synthetic liposomes , 2009, Biotechnology and bioengineering.

[78]  J. D. Bell,et al.  The influence of membrane physical properties on microvesicle release in human erythrocytes , 2009, PMC biophysics.

[79]  R. Gascoyne,et al.  Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma , 2009, Cancer.

[80]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[81]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[82]  Ikuo Morita,et al.  Direct formation of proteo-liposomes by in vitro synthesis and cellular cytosolic delivery with connexin-expressing liposomes. , 2009, Biomaterials.

[83]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[84]  Genevieve DeMaria,et al.  Characterization of exosome‐like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  G. Moseley,et al.  Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells , 2009, Immunology.

[86]  G. Tsongalis,et al.  MicroRNAs: novel biomarkers for human cancer. , 2009, Clinical chemistry.

[87]  R. Kerbel,et al.  Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR , 2009, Proceedings of the National Academy of Sciences.

[88]  John R Yates,et al.  Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). , 2009, Journal of proteome research.

[89]  B. Brenner,et al.  Microparticles, thrombosis and cancer. , 2009, Best practice & research. Clinical haematology.

[90]  Sung Wan Kim,et al.  Efficient siRNA Delivery with Non-viral Polymeric Vehicles , 2009, Pharmaceutical Research.

[91]  D. Polsky,et al.  Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.

[92]  Trairak Pisitkun,et al.  Large-scale proteomics and phosphoproteomics of urinary exosomes. , 2009, Journal of the American Society of Nephrology : JASN.

[93]  John J. Rossi,et al.  The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.

[94]  Rong-Fong Shen,et al.  Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. , 2009, Biochemical and biophysical research communications.

[95]  J. Keski‐Oja,et al.  Secretion of active membrane type 1 matrix metalloproteinase (MMP‐14) into extracellular space in microvesicular exosomes , 2008, Journal of cellular biochemistry.

[96]  F. Besson,et al.  Interactions of Triton X-100 with sphingomyelin and phosphatidylcholine monolayers: influence of the cholesterol content. , 2008, Colloids and surfaces. B, Biointerfaces.

[97]  B. Brenner,et al.  Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells , 2008, Thrombosis and Haemostasis.

[98]  R. Simpson,et al.  Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.

[99]  M. Hemler Targeting of tetraspanin proteins — potential benefits and strategies , 2008, Nature Reviews Drug Discovery.

[100]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[101]  Eugene A. Kapp,et al.  Difference gel electrophoresis analysis of Ras‐transformed fibroblast cell‐derived exosomes , 2008, Electrophoresis.

[102]  R. Schiffelers,et al.  Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells. , 2008, Blood.

[103]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[104]  T. Cotter,et al.  Morphological assessment of apoptosis. , 2008, Methods.

[105]  J. Lawler,et al.  Thrombospondins in cancer. , 2008, Cellular and molecular life sciences : CMLS.

[106]  C. Théry,et al.  Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.

[107]  F. Szoka The Art of Assembly , 2008, Science.

[108]  P. Cullis,et al.  Liposomal nanomedicines , 2008, Expert opinion on drug delivery.

[109]  A. Kamen,et al.  Identification of Host Proteins Associated with Retroviral Vector Particles by Proteomic Analysis of Highly Purified Vector Preparations , 2007, Journal of Virology.

[110]  H. Kwon,et al.  Proteomic analysis of microvesicles derived from human colorectal cancer cells. , 2007, Journal of proteome research.

[111]  T Takahashi,et al.  Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 , 2007, Oncogene.

[112]  J. Lawler,et al.  Thrombospondin-based antiangiogenic therapy. , 2007, Microvascular research.

[113]  B. Furie,et al.  Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII. , 2007, Journal of molecular biology.

[114]  N. Hogg,et al.  CD8+ Dendritic Cells Use LFA-1 to Capture MHC-Peptide Complexes from Exosomes In Vivo1 , 2007, The Journal of Immunology.

[115]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[116]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[117]  John J. Rossi,et al.  Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.

[118]  M. Record,et al.  Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. , 2007, Biochimie.

[119]  J. Lenormand,et al.  Production of membrane proteins using cell–free expression systems , 2007, Expert review of proteomics.

[120]  Vincent De Guire,et al.  An E2F/miR-20a Autoregulatory Feedback Loop* , 2007, Journal of Biological Chemistry.

[121]  Ilpo Vattulainen,et al.  Assessing the Nature of Lipid Raft Membranes , 2007, PLoS Comput. Biol..

[122]  B. Rothen‐Rutishauser,et al.  Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. , 2006, The American journal of pathology.

[123]  O. Barreiro,et al.  Tetraspanins CD9 and CD81 Modulate HIV-1-Induced Membrane Fusion1 , 2006, The Journal of Immunology.

[124]  V. Dötsch,et al.  Cell‐free expression as an emerging technique for the large scale production of integral membrane protein , 2006, The FEBS journal.

[125]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[126]  J. Winter,et al.  Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug , 2006, Expert opinion on biological therapy.

[127]  C. Futter,et al.  EGF stimulates annexin 1‐dependent inward vesiculation in a multivesicular endosome subpopulation , 2006, The EMBO journal.

[128]  R. Schiffelers,et al.  RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[129]  M. Hemler Tetraspanin functions and associated microdomains , 2005, Nature Reviews Molecular Cell Biology.

[130]  Z. Fishelson,et al.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer , 2005, Springer Seminars in Immunopathology.

[131]  G. Moseley,et al.  Tetraspanins in Viral Infections: a Fundamental Role in Viral Biology? , 2005, Journal of Virology.

[132]  P. Paz,et al.  Exosome Display technology: applications to the development of new diagnostics and therapeutics. , 2005, Blood cells, molecules & diseases.

[133]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[134]  L. Santambrogio,et al.  Proteomic Analysis of Microglia-Derived Exosomes: Metabolic Role of the Aminopeptidase CD13 in Neuropeptide Catabolism1 , 2005, The Journal of Immunology.

[135]  C. Théry,et al.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. , 2005, Blood.

[136]  Olivier Lantz,et al.  Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.

[137]  J. Le Pecq,et al.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.

[138]  J. Freyssinet,et al.  Membrane microparticles: two sides of the coin. , 2005, Physiology.

[139]  B. Meyer,et al.  Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomes. , 2005, Journal of the American Chemical Society.

[140]  Simon C Watkins,et al.  Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. , 2004, Blood.

[141]  M. Hristov,et al.  Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. , 2004, Blood.

[142]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[143]  S. Moutel,et al.  CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. , 2004, Blood.

[144]  M. Radic,et al.  Apoptosis, subcellular particles, and autoimmunity. , 2004, Clinical immunology.

[145]  M. Rots,et al.  A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. , 2004, Human gene therapy.

[146]  Bart N Lambrecht,et al.  Proteomic analysis of exosomes isolated from human malignant pleural effusions. , 2004, American journal of respiratory cell and molecular biology.

[147]  W. Faigle,et al.  Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[148]  Aled Clayton,et al.  Adhesion and signaling by B cell‐derived exosomes: the role of integrins , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[149]  Sébastien Roy,et al.  Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. , 2004, The Biochemical journal.

[150]  M. Hemler Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. , 2003, Annual review of cell and developmental biology.

[151]  M. Kozlov,et al.  Protein-lipid interplay in fusion and fission of biological membranes. , 2003, Annual review of biochemistry.

[152]  K. Shedden,et al.  Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. , 2003, Cancer research.

[153]  E. Mekada,et al.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes , 2003, The Journal of cell biology.

[154]  J. Slot,et al.  Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.

[155]  Aled Clayton,et al.  Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.

[156]  T. Imura,et al.  Membrane properties of mixed dipalmitoylphosphatidylglycerol/ganglioside GM3 liposomes in the presence of bovine serum albumin , 2003 .

[157]  C. Théry,et al.  Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes , 2002, Nature Immunology.

[158]  J. Slotte,et al.  Membrane properties of sphingomyelins , 2002, FEBS letters.

[159]  G. Valesini,et al.  The clearance of apoptotic cells: implications for autoimmunity. , 2002, Autoimmunity reviews.

[160]  D. Praticò,et al.  Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. , 2002, Experimental hematology.

[161]  P. Hinterdorfer,et al.  Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. , 2002, Blood.

[162]  N. Mohandas,et al.  Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[163]  B. Meyer,et al.  Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alphaIIbbeta3. , 2001, Journal of medicinal chemistry.

[164]  P. Cullis,et al.  Roles of lipid polymorphism in intracellular delivery. , 2001, Advanced drug delivery reviews.

[165]  A. Namane,et al.  Nonspecific B and T Cell-Stimulatory Activity Mediated by Mast CellsIs Associated with Exosomes , 2001, International Archives of Allergy and Immunology.

[166]  A. Namane,et al.  Mast Cell-Dependent B and T Lymphocyte Activation Is Mediated by the Secretion of Immunologically Active Exosomes1 , 2001, The Journal of Immunology.

[167]  C. Mold,et al.  Cooperation between decay accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack , 2000 .

[168]  S. Fedosov,et al.  Functional analyses of two cellular binding domains of bovine lactadherin. , 2000, Biochemistry.

[169]  E. Mekada,et al.  Requirement of CD9 on the egg plasma membrane for fertilization. , 2000, Science.

[170]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[171]  Laurence Zitvogel,et al.  Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.

[172]  M. Hemler,et al.  Role of Transmembrane 4 Superfamily (Tm4sf) Proteins Cd9 and Cd81 in Muscle Cell Fusion and Myotube Maintenance , 1999, The Journal of cell biology.

[173]  R. Bucki,et al.  Calcium induces phospholipid redistribution and microvesicle release in human erythrocyte membranes by independent pathways. , 1998, Biochemistry.

[174]  D. Devine,et al.  Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. , 1998, Archives of biochemistry and biophysics.

[175]  H. Geuze,et al.  Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.

[176]  T. Ishida,et al.  Characterization of bovine serum factor triggering the lysis of liposomes via complement activation. , 1998, Biological & pharmaceutical bulletin.

[177]  J. Engel,et al.  Integrin alphaIIb beta3 reconstituted into lipid bilayers is nonclustered in its activated state but clusters after fibrinogen binding. , 1997, Biochemistry.

[178]  T. Sasaki,et al.  Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. , 1993, The Journal of biological chemistry.

[179]  T. Allen,et al.  Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. , 1991, Biochimica et biophysica acta.

[180]  D Needham,et al.  Elastic deformation and failure of lipid bilayer membranes containing cholesterol. , 1990, Biophysical journal.

[181]  P. Sims,et al.  The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. , 1990, Journal of immunology.

[182]  Shlomo Nir,et al.  Molecular mechanisms of calcium-induced membrane fusion , 1990, Journal of bioenergetics and biomembranes.

[183]  J. Philippot,et al.  Asymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of guinea pig reticulocytes: Evidence precluding a role for “aminophospholipid translocase” , 1989, Journal of cellular physiology.

[184]  P. Williamson,et al.  Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[185]  T M Allen,et al.  Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.

[186]  N. Crawford The Presence of Contractile Proteins in Platelet Microparticles Isolated from Human and Animal Platelet‐free Plasma , 1971, British journal of haematology.

[187]  P. Wolf The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[188]  郑俊海,et al.  科技期刊稿件处理的精细化管理——《International Journal of Nanomedicine〉〉投稿体会 , 2014 .

[189]  Ciro Tetta,et al.  Exosome/microvesicle-mediated epigenetic reprogramming of cells. , 2011, American journal of cancer research.

[190]  V. Dötsch,et al.  Strategies for the cell-free expression of membrane proteins. , 2010, Methods in molecular biology.

[191]  Michele Guescini,et al.  Astrocytes and Glioblastoma cells release exosomes carrying mtDNA , 2009, Journal of Neural Transmission.

[192]  Robert Blumenthal,et al.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.

[193]  M. Zöller Tetraspanins: push and pull in suppressing and promoting metastasis , 2009, Nature Reviews Cancer.

[194]  A. Ho,et al.  Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis , 2008, Cell Death and Differentiation.

[195]  松原 秀雄 Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 , 2007 .

[196]  N. Demaurex,et al.  Endosome-to-cytosol transport of viral nucleocapsids , 2005, Nature Cell Biology.

[197]  F. Maxfield,et al.  Endocytic recycling , 2004, Nature Reviews Molecular Cell Biology.

[198]  M. Vidal,et al.  Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. , 2000, European journal of biochemistry.

[199]  M. Vidal,et al.  Exosomes released during reticulocyte maturation bind to fibronectin via integrin α4β1 , 2000 .